Skip to Main Content

Paper Details

Trotabresib, an oral potent bromodomain and extraterminal inhibitor, in patients with high-grade gliomas: A phase I, "window-of-opportunity" study.
Neuro Oncol
8
2023
Author NameAffiliation
Michael A VogelbaumMoffitt Cancer Center
  • 1 - 1

Datasets

Release 1.2